Cayman

STING R224 variant (human, recombinant)

CHF 909.00
In stock
CAY-23593-100100 µgCHF 909.00
 
More Information
Product Details
Synonyms Endoplasmic Reticulum Interferon Stimulator; Stimulator of Interferon Genes; TMEM173
Product Type Protein
Properties
Sequence N-terminally Histidine-tagged human STING R232, K224R mutant purified from E. coli.
Purity ≥70% (SDS-PAGE)
Formulation 50 mM HEPES, pH 8.0, with 150 mM sodium chloride, and 10% glycerol
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

Declaration Manufactured by Cayman Chemicals.
Shipping and Handling
Shipping DRY ICE
Long Term Storage -80°C
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description
STING R224 variant (human, recombinant) contains amino acids 138-379 of the wild-type variant (R232) with lysine 224 substituted with arginine. Stimulator of interferon genes (STING) is a component of the innate immune response that binds to cyclic dinucleotides, which are bacterial second messengers, leading to activation of NF-κB and transcription of immunomodulatory genes, including type I interferon (IFN). The R232 variant of STING is the most common variant in the human population, found at a frequency of 57.9% in the 1000 Genome Project. The SNP variant H232 is found at a 13.7% frequency. The K224R mutation prevents ubiquitination of STING at position K224, a process which is essential for efficient cytosolic DNA-mediated signaling. Therefore, this mutation disrupts optimal STING trafficking, which inhibits TBK1-mediated IRF3 activation but not NF-κB activation.
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.